We strongly recommend discussing the ingredients with your physician before use
However, Neurobion injection may contain higher pharmacological doses, and its use in breastfeeding women should be guided by a doctor
UPDATE: On January 8, 2024, Hangzhou Jiuyuan Gene Engineering became the second Chinese company to receive permission for the clinical trial of the class 3.3 biosimilar semaglutide for weight control, according to the website of the Center for Drug Evaluation (CDE)
Patients who might consider using Victoza include: Those with documented leptin resistance Those with documented insulin resistance Those with weight loss resistance (inability to lose weight despite diet and exercise) Most people who are interested in long-term and sustained weight loss Those with PCOS, estrogen dominance, or other hormone imbalances that may lead to weight gain Victoza may not work for ALL individuals but it has a very high success rate for those who use it correctly
however, there are other mechanisms by which hormones, particularly estrogen, may contribute to BPPV